Trial Search Results

Predicting Outcomes for Covid-19 Using Sonography

This study seeks to investigate the role of lung ultrasound in caring for Covid-19 positive patients and whether it can be used to predict patient deterioration. This information will be vital for healthcare workers who seek to identify Covid-19 pneumonia or patients at risk for deterioration early in the disease course.

Stanford is currently accepting patients for this trial.

Lead Sponsor:

Stanford University

Stanford Investigator(s):


  • Diagnostic Test: Lung Ultrasound


Inclusion Criteria:

   - Any adult (18 or more years of age) presenting to the emergency department with
   symptoms suspicious for Covid-19

   - This individual underwent evaluation for Covid-19 via a nasopharyngeal RT-PCR

   - This individual received a lung ultrasound by the study authors within 28 days from
   initial evaluation

Exclusion Criteria:

   - Any individual who did not receive a lung ultrasound within 28 days from initial
   evaluation for covid-19 related illness

Ages Eligible for Study

18 Years - N/A

Genders Eligible for Study


Now accepting new patients

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305